Oximio, South Africa, Attains an Additional Resolution to SAHPRA Licence, Paving the Way for Medical Cannabis Innovation

Oximio, South Africa, is delighted to announce that it has secured a resolution to the SAHPRA (South African Health Products Regulatory Authority) licence for the handling of medical cannabis. This marks a significant milestone in the company’s journey and means that Oximio, South Africa, has the capability to support all licensed manufacturers and cultivating farms in the transportation of medical cannabis for exportation from South Africa. Furthermore, Oximio, South Africa, is now able to accept medical cannabis for storage on behalf of local manufacturers and cultivators.